Skip to main content
VCbacked
Log inGet Started

OnCusp Therapeutics

New York, United States

OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.

$100.0M raised
Jan 2024
Series A
BiotechnologyHealth CareOncologyPharmaceuticalProduct Research

Top Investors

HSGBlackbird VenturesCatalio Capital ManagementOrbiMedF-Prime Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about OnCusp Therapeutics

How much funding has OnCusp Therapeutics raised?
OnCusp Therapeutics has raised $100.0M in total funding. The most recent round was Series A. The last funding was announced in January 2024.
Who are OnCusp Therapeutics's investors?
OnCusp Therapeutics's investors include HSG, Blackbird Ventures, Catalio Capital Management, OrbiMed, F-Prime Capital.
Where is OnCusp Therapeutics headquartered?
OnCusp Therapeutics is headquartered in New York, United States.
What does OnCusp Therapeutics do?
OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.
What stage is OnCusp Therapeutics at?
OnCusp Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"OnCusp Therapeutics — Funding & Investors." VCBacked, January 4, 2024, https://www.vcbacked.co/company/oncusp-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2024). OnCusp Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/oncusp-therapeutics
Wikipedia (cite web)
{{cite web |title=OnCusp Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/oncusp-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong